DT
HealthMore in Health→
A Hybrid Obesity-Drug Concept Aims to Tackle Diabetes at the Same Time
Key Takeaways
- Helmholtz Munich researchers described a hybrid molecule for obesity and type 2 diabetes.
- The approach uses GLP-1 and GIP signaling together in one drug concept.
- The announcement highlights a broader shift toward integrated metabolic therapies.
DE
DT Editorial Team··via medicalxpress.com